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Introductio~t:  There is ongoing controversy 
regarding  the appropriate use  of  narcotic 
analgesia for patients presenting frequently to the 
emergency department (ED) with subjective 
acute exacerbations of pain. "Are we treating pain 
or enabling  Objectives: To determine 
whether the presence sf specific factors could 
be used to identify adults complaining of  acute 
exacerbations  sf pain  for  suspected  drug 
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addiction, "E  es$!ma&e the percentage of  drug 
addicted patients, to assess the physlcie3s5 ability 
Lo  detect drag addic<isn;  and Bs  evaluate interrater 
x-eliabiiltj~~  Merho&:  A Drug Abnse Screening Test 
(EAST-20)  was e6minlste~ed  40  76 E2  patients 
who preseated with acste exacerbations sf palw 
and either multiple XD  visits  for simZa7 pain 
complaints,  s~ecific  narcotic  req~esf~s,  OF 
66aBiZergies99  to now-warcofics,  The DhST-28 v~~cres 
also administeered  t3 74 age-rnztched 2ontroSs. 
Treating E9  physicians rated their sespicion for 
drug addiction wSng a vlsatai anaiog scale ("AS). 
Results: The oe~era'li  estimation off  dmg addiction 
based on the DAST-20 snrvej was 873%  (26k 
150). Twenty-one percent (46k76) sf the analgesia 
subjects and 13,5%  ($0674) of the control subjects 
scored positive for drug addiction as measured 
by  the DAST-20. Of  the analgesia subjects with 
positive  DAST-20 scores for drug addiction, 
433% (7116) had multiple ED visits, 43,8% (71 
16) requested specific narcotics and 6.3% (1116) 
reported 66allergies9'  $0 non-narcotics, There was 
no correlation between the VAS scores and &he 
DAST-20  scores,  These  was  a  significant 
correlation between resident and attending VAS 
scores for their suspicion for drug addiction, 
Conclusion:  There exists a cliwically significant 
drug addiction problem among ED patients 
presenting with acnte exacerbations of  pain and 
among Sow-acuity patients who do xs$  grese~qt  $0 
the ED for pain management, 
INTRODUCTION 
Appropriate pain management is a topic of cur~ea-at 
debate. There is ongoing conzoversy regarding the 
proper use of  narc~tic  analgesia f~r  patients 
presenting  to the emerge1r.c-y department with 
subjective  acnte e:aracerba~ioi.s  of pain.'-'! There a-e 
c  reW scientific studies that invesligzte the actilia1 
prevalence of  adciction in patients frequently 
.  ~ 
reqmnalg anaslalgesia in the emergency deparrtrnent~"- 
l4 More, than 50  rjiilisn Americans suffer from 
chronic pain th&  YP&~U~~S  najcC3li~s  foj: j+?ji~  rc~,"ef. 
.  ~  1,1998,1.4  yxlllEsn h~~ebcaps  abusei,  prescnptrcln 
~  --  ~  pin  relievers.' According to the ~J~TIQI?~;  .csntnte 
of Drug Abuse,  fiere ~l-e  aver 4 million adu"s 
-  "  ~  ~ 
aDusli9~  L.  psyckaa-dve prescrlpf;:on 1_;2&.icatio- for 
nsen?~&cd  i.easons.l6 
-7  3 ne Caiifor:lia  .Jojrn;:i  of Ejy_..er~i.ficy  L.  h/Iedic;~je  '\!I:  :. J:ln-h/lai. 2005 
~  ---  ----------m--p---p------.---7,-m 
We investigated whether the presence of specific 
factors could be used to identify adiilts corYpPaining 
of acute exacerbations of pain for suspected drug 
addiction.  01-K  other objectivzs were to estimate the 
percentage of drug addicted patients, to assess the 
physicians' ability to detect drug addiction and to 
evaluate inter-rater reiiabifity. 
DAATERIALS AND il4ETHODS 
aduh patients compPaining of  acute exacehation 
of ~aia  who presented to the emergency department 
(ED) were vooluntx~iy  recruited for this survey study, 
as illustrated by the Wow  chart in Figure I.  The ED is 
a university-based level I trauma center, with an 
accredited emergency medicine residency program, 
&at treats more than 45,000  patients annually. The 
triage nurse identified potentid s~~bjects  for the survey 
study with the following inclusion  criteria: (a) specific 
narcotic requests, (b) ""allergies" to non-narcotic 
an~algesics,  or (c) 2 or more prior ED visits for similar 
pain complaints within the past 6 months. Exclusion 
criteria included any objective pathological or 
anatomic disease, s~~h  as neoplasia, acute trauma, 
toxic exposure, Section,  fiacmre,  burn, idamation, 
isckmk,  idxct,  peritonitis, hemat010gHc disorder?  or 
specific  rheumatologic, efidocrine or ccobgpective tissue 
disease, or any life-threatening condition. Patknts in 
exsemis  were exciuded, a5 were minors, prisoners, 
pregnant patients and the mentally hnpahed. For each 
analgesia szbject,  an zge-matched co~-~&ol  was enrolled CJ  I  ILILIJ~,  Tc  LII fiai br 1:rr,e~!=.encj htedjc  3~~:  \#'I 1 i~tfi-?~I‘tr  2(1)5  Pagz  5 
via the next low-acuity patient, triaged of the same  an estimate for each subject's suspicion for drug 
sex and within 5 years of age.  addiction. Zero indicated "no addiction risk" and 10 
'"bsolutely  certain addiction." These VAS scores were 
Consenting subjects completed the self-ad~Miistered  later con-elated anonymoersly to the scores from the 
Drug Abuse Screening Test (DAST-20) distributed  DAST-20 in order to assess the ability of the ED 
by  the research personnel  from the Emergency  physicians to detect drug addiction. 
Medicine Research Associates Program (EMUP), 
see Figure 2. The DAST-20 is a previously validated  Data were analyzed using  STATA 7.0 (Stata 
survey tool that measures d-rug addiction via 20 yes/  Corporation, College Station, TX) and results were 
no questions, exclusive of  alc~hol.'~  l8  This  reported  as counts and percentages with 95% 
rneas~~rement  tool has a specificity of 92%, sensitivity  confidence intervals (CI). 
of 74 56,  positice predictive value of 8396, negative 
predictive value of 85%, and  overall accuracy of 84%,  The institutional review board at our center approved 
as reported by Skinner.'' These dlagnostnc valuec  this study protocol under expedited category. with 
pertain to a DAST-20 cutoff score of 10 which meets  the requirement for written consent and distr?~ution 
the Diagnostic and Statistical Manual of Mental  of patient bill of rights to all enrolled subjects. 
Disorders-Third Edition (DSM-III) criteria for drug 
addiction.l7.'We  used thir same ce~tofZ'vdue.  Subjects  mSULTS 
were assured of anonymity and that their DAST-20 
scores were blinded horn the treating physic~an.  The  The overall estimation of drug addiction among this 
subjects' ED course was uhindered by the survey.  study population was 17.3% (261150) as assessed 
by a DAST-20 score of  10 or greater. Of the 76 
The treating resident and attending physici;~~  assigned  analgesia subjects, 2 4.1  % (I 6/76) scored positive for 
a Visual Analog Scale (WS)  score from 0 to 10 as  drug addiction by the DAST-20. Of the 74 control 
Figure 2. The Drug Abuse Screening Test (DAST-20)  1 
The fol!owi:lg  questions concern inforinatiol~  about your in~olvement  and abuse of drugs. Drug abuse refers to:  1 
(1) The use of prescribed or 'hover-the-cotulti;-"  drugs in excess of the directions.  1 
(2) Any non-medical use of drugs.  1 
The cluestio~~s  1190  NOT include alcoholic beverages. The DAST does not include alcohol use.  S 
1 
The questions refer to the past 12 months. Carefully read each statement and decide whether your answer is yes or no.  1 
Please give the best answer or the answer that is right most of the time. Click on the box for Yes or No. 
1.  Have you used drugs other than those required for medical reasons? Yes No 
2.  Have you abused prescription  drugs? Yes No 
3.  Do you abuse more than one drug at a time? Yes No 
4.  Can you get through the week without using drugs? Yes No 
5.  Are you always able to stop using drugs when you want to? Yes No 
6.  Have you had "blacltouts"  or "ilashbacks" as a result of drug use? Yes No  I 
7.  Do you ever feel bad or guilty about your drug use? Yes No  I 
8.  Does your- spouse (or parents) ever complaill about your involvement with drugs? Yes No 
9.  Has drug abuse created problems between you and your spouse or your parents? Yes No  I 
10.  Have you lost friends because of your use of drugs'? Yes No  I 
11.  Have you neglected your family because of your use of drugs? Yes  No  I 
12.  Have you been in trouble at worlc because of your use of drugs? Yes No 
13.  Have you lost a job because of drug abuse? Yes No 
14.  Have you gotten into fights when under the inf!uence  of drugs? Yes No 
15.  Have you engaged in illegal activities in order to obtain drugs? Yes No 
16.  Have you been arrested for possession of illegal drugs? Yes No  r  17.  Have )ou ever experienced withdrawal syrnptoms (felt sick) when you stopped taking drugs'? Yes No  1 
18.  Have you had medical problems as a result of your drug ~ase?  (eg, memory loss. hepatitis. convulsions. etc.) Yes NO/ 
I 
19.  Ha~e  you gone to anyolle for help for a drug problem? Yes No 
20.  Have you been invol\ ed in a treatrne~lt  program especially related to drug use? Yes No  1 
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subjects, 13.5'30 (10134) scored positive for drug 
addiction by the DAST-20. Wie were unable to find a 
significant  difference between the propofiions (0.135 
and 0.21 1) of control and analgesia group subjects 
with DAST-28 scores of  10 or greater. We were 
unable to detect a clinicdy relevant d8erence  b, Ptween 
the control and analgesia group DAST-20 scores. 
Among the sample population in those subjects who 
presented to the ED with acute exacerbations of pain, 
48.9% (37176) had multiple ED visits, 1 4.8% ((9176) 
reported an '6dallergy"  to non-narcodcs and 42.1% (321 
76) requested specific narcotics for pain control. 
Thirty-four percent (25176) of  the subjects had 
nnultiple ED visits for acute exacerbations of pain ,and 
specific narcotic requests. 
Positike DAST-20 scores for drug addiction are as 
follows: (a) 43.8% (7116) for multiple visits, (b) 43.8% 
(711 6) for specific narcotic requests, and (c) 6.3% 
((111  6) for "allergies9'  to non-narcotics. The ~~aajoi-ity 
of patients with a drug addiction problem meacured 
by the DAST-20 were subjects who reqraected a 
specific narcotic and those subjects wit11 multiple ED 
visits for pain control.  No single factor or combination 
offactors was associated with an increased rate of 
drug addiction as estimated by the DAST-20. 
There was no relationship between positive DAST- 
20 scores for dmg addiction and multiple ED visits, 
specific narcotic requests or "allergies"  to non- 
narcotics (p=0.574,0.293  and 0.975, respectively). 
There was no correlation between the physician index 
of suspected drug addiction as measured by the VAS 
and the estimated rate of drug addiction as measured 
by the DAST-28 (r=0.833, p=0.70.95% 'GI: -0.430 
to 0.194). 
We were unable to detect differences between sample 
subjects with DAST-20 scores of less than I0  (n-60) 
and those with DAST-28 scores of  10 or greater 
(n-16)  with regad  to nmltiple ED visits for acute pain 
exacerbations (0.50 and 0.4331, "'allergies" to non- 
narcotics (0.9  33 and 0.063), or subjects requesting 
specific narcotics (0.41  7 and 0.438). 
DISCUSSION 
This is the first prospective st~idy  investigating drug 
addiction  among ED patients  with acute pain 
exacerbations. In a recent survey, the majority of 
physicians reported a great ambivalence concerr~ing 
controlled drug prescribing: their desire to relieve pain 
and discomfort along with fear of creating addiction 
and being inve~tigated  by law enforce~nent  a~fhorities.~ 
This dilemma has created much debate regarding tne 
role of proper pain management in less well-defined 
pain syndromes usually  perceived to have 
psychosocial components, for example n~yofascial 
syn&omes, lower back pain. toothache or headache 
without apparent definitive objective findings. 
Clinicians have sought to treat these types of patients 
wit11 analgesics. The vast majority of these patients 
do not become addicted. However. at the same time 
the clinician is trying to minimize those rare patients 
who do abuse, divert or become addicted. 
The DAST-20 was used in this study as a measu~re~nent 
for drug invol~ement  among ED patients presenting 
with acute exacerbations of pain. The DAST-20 was 
developed by Skinner in 1 982 to provide a screening 
device for drug abuse or dependence as defined by 
DSM-IT6 diagnostic criteria. The study consisted of 
drug abuse clients at a psychiatricldr~zg  treatment 
center with a known dmg dependel~cy  problem. The 
subjects were pain-free, willing paicipants in the study 
seeking care for drug depenidency. The data was 
validated against DSM-%I1  drug abuseldependency 
criteria. The DAST-20 is only moderately correlated 
with denial.  ' 
This is the first study to use the DAST-20 as a 
measurement tool for drug addiction in the primary 
care setting where the patient is presenting with pain 
complaints and seeking pain control. The DAST-20 
may be ¶awed in that the evduation is of limited value 
in a drug dependent person who denies drug use. The 
DAST-20 survey estimated dmg addiction in 17.3% 
(2611 50) of the overall study population, 2 I.  I '3%  ((1 61 
'76) in the analgesia group and 4 3.5  5%  (  (1 0174) in the 
control group. These percentages  are clinically 
relevant, indicating that drug addiction exists among 
patients that present to the ED for acute exacerbations C:i!ifori:i:!  Jou:-iii  of E;nergei~-~  b'iedici;e ":I:  1,  Jail-Wt:;:.  2965 
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of pain, as well as in a subset of low-acuity patients 
that do not present to the ED for a primary complaint 
of gain management. 
The lack of correlation between the DAST-20 scores 
and the VAS scores implies that ED physician\ are 
unable to accurately assess drug addiction. However, 
the attelzdiag VAS scores cowelated wit11 the sum of 
the three factors (multiple vislts for pain exacerba~ons, 
\peclfic narcotic reqhlests and ""aPPergies" to non- 
narcotics). This suggests that the physician should be 
aware that patients who present with one or more of 
these factors may have drug-seeking behaviors. 
Tne number of analgesia subjects that were originally 
approached for the  DAST-20 survey was 
approximately two times the final sample size. The 
~najority  of the control subjects that were approached 
for the DAST-20 survey participated in the study. 
Drug-seeldng for diversion or addiction is potentiall-y 
a strong motivation for non-participation, A subject 
that is truly dmg-seeking may be unlikely to admit to 
that fact even if promised that their admission would 
not be  e~sed  "against" them. 
The major limitation of this study is the fact that the 
DAST-26)  has not been validated in the ED setting. 
For the DAST-20 to be a true gold standard it must 
be validated in the ED setting for the results to be 
valid and cfiaapcdly relevant for the estimation of drug 
addiction. 
The second limitation of the study was the sample 
size. We were underpowered to detect clinically 
significant differences in drug addiction between the 
control and analgesia groups. The 39% difference 
between these two groups for drug addiction (21  5% 
vs. 13%)  in this study was not clinically significant.  By 
increasing the power (sample size) the type 11 en-or 
would be decreased, thus minimizing the risk of 
deciding that no effect or difference exists when 
inadequate numbers have been examined. 
Pdge  7 
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the findings may not be generalized to all subjects 
presenting to the ED with acute exacehations of pain. 
Lastly denial and under-repo~ting  drug involvement 
would limit the accuracy and re-eliabiliq  of the DAST- 
26) scoreu. This could have ultimately affected the 
statistical analysis and interpre~ition  of our study data. 
Many cfinicims IPdc  that it is more ethical, if a patient 
claims pain, to err on the side of pain relief. Others 
believe that the greater danger lies in creating access 
to dr~~gs  for ab~~sers,  diverters. or addicts, which may 
result in harm to themselves or  Such 
judgments must be made on a case-by-case basis 
according to the context and the values of the clinician 
If the physician denies pain mmage~nen?B,  the physician 
has an  ethical duty of  involving an addiction 
professional,''  In a recent survey, nearly 4'9% of 
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